Mohamed AF - Search Results

1

Physician preferences for bone metastasis drug therapy in Canada.

Arellano J, González JM, Qian Y, Habib M, Mohamed AF, Gatta F, Hauber AB, Posner J, Califaretti N, Chow E. Arellano J, et al. Among authors: mohamed af. Curr Oncol. 2015 Oct;22(5):e342-8. doi: 10.3747/co.22.2380. Curr Oncol. 2015. PMID: 26628874 Free PMC article.

2

Patient preferences for treatments to delay bone metastases.

Hauber AB, Arellano J, Qian Y, González JM, Posner JD, Mohamed AF, Gatta F, Tombal B, Body JJ. Hauber AB, et al. Among authors: mohamed af. Prostate. 2014 Nov;74(15):1488-97. doi: 10.1002/pros.22865. Epub 2014 Aug 17. Prostate. 2014. PMID: 25132622

3

Physicians' preferences for bone metastases drug therapy in the United States.

Arellano J, Hauber AB, Mohamed AF, Gonzalez JM, Collins H, Hechmati G, Gatta F, Qian Y. Arellano J, et al. Among authors: mohamed af. Value Health. 2015 Jan;18(1):78-83. doi: 10.1016/j.jval.2014.10.004. Value Health. 2015. PMID: 25595237 Free article. Clinical Trial.

4

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.

Hauber AB, Mohamed AF, Johnson FR, Falvey H. Hauber AB, et al. Among authors: mohamed af. Diabet Med. 2009 Apr;26(4):416-24. doi: 10.1111/j.1464-5491.2009.02696.x. Diabet Med. 2009. PMID: 19388973

5

Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma.

Mohamed AF, Hauber AB, Neary MP. Mohamed AF, et al. Pharmacoeconomics. 2011 Nov;29(11):977-88. doi: 10.2165/11593370-000000000-00000. Pharmacoeconomics. 2011. PMID: 21854079

6

Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.

Hechmati G, Hauber AB, Arellano J, Mohamed AF, Qian Y, Gatta F, Haynes I, Bahl A, von Moos R, Body JJ. Hechmati G, et al. Among authors: mohamed af. Support Care Cancer. 2015 Jan;23(1):21-8. doi: 10.1007/s00520-014-2309-x. Epub 2014 Jun 18. Support Care Cancer. 2015. PMID: 24939674 Free PMC article.

7

Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.

Qian Y, Arellano J, Hauber AB, Mohamed AF, Gonzalez JM, Hechmati G, Gatta F, Harrelson S, Campbell-Baird C. Qian Y, et al. Among authors: mohamed af. Patient. 2016 Aug;9(4):323-33. doi: 10.1007/s40271-015-0158-4. Patient. 2016. PMID: 26821359 Free PMC article.

8

Benefit-risk tradeoff preferences for chronic hand eczema treatments.

Hauber AB, Mohamed AF, Gonzalez JM, Otteson Fairchild A, Zelt SC, Graff O. Hauber AB, et al. Among authors: mohamed af. J Dermatolog Treat. 2017 Feb;28(1):40-46. doi: 10.1080/09546634.2016.1177161. Epub 2016 May 10. J Dermatolog Treat. 2017. PMID: 27160959

9

Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.

Qian Y, Arellano J, Gatta F, Hechmati G, Hauber AB, Mohamed AF, Bahl A, von Moos R, Body JJ. Qian Y, et al. Among authors: mohamed af. BMC Health Serv Res. 2018 Jul 3;18(1):518. doi: 10.1186/s12913-018-3272-x. BMC Health Serv Res. 2018. PMID: 29970078 Free PMC article.

10

Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.

Mohamed AF, Johnson FR, Hauber AB, Lescrauwaet B, Masterson A. Mohamed AF, et al. Eur J Gastroenterol Hepatol. 2012 Apr;24(4):419-26. doi: 10.1097/MEG.0b013e328350914c. Eur J Gastroenterol Hepatol. 2012. PMID: 22330238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page